A comprehensive view of Neurological/Cognitive Health. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Neurogene announces FDA clearance of IND for NGN-401 gene therapy for children with Rett syndrome; Rett syndrome is an X-linked, progressive, neurodevelopmental disorder that affects 1 in 10,000 live female births
Published: January 23, 2023 by Business Wire
Eli Lilly reports FDA has rejected accelerated approval for its donanemab Alzheimer’s drug due to insufficient data from patients who used the drug for a year; donanemab removes amyloid protein plaques from the brains of people with early Alzheimer's
Published: January 20, 2023 by International Business Times
Reunion Neuroscience appoints Robert Alexander, M.D. as Chief Medical Officer; Dr. Alexander previously served as VP and Head of Clinical Science in the Neuroscience Therapeutic Area Unit at Takeda Pharmaceuticals
Published: January 18, 2023 by GlobeNewswire
Mintel: In 2023, consumers to seek food/drink that helps with cognitive capacity, managing stress, optimizing brain function; other trends include experiential eating, meat substitutes, food for weather-related disasters, female health food, upcycled food
Published: January 10, 2023 by Courier Mail
FDA grants accelerated approval to Biogen and Eisai's anti-amyloid beta protofibril antibody candidate Leqembi lecanemab to treat early Alzheimer's disease; Eisai has set wholesale acquisition cost for the drug at US$26,500 per year
Published: January 10, 2023 by Zack's Commentary

Ask us about our Tissue & Hygiene market view

Trending Chart

Interactive chart with headline count